Macronix International Co Ltd
TWSE:2337
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Macronix International Co Ltd
TWSE:2337
|
TW |
|
B
|
BioMarin Pharmaceutical Inc
XMUN:BM8
|
US |
Dividends
Dividend Yield
Macronix International Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Macronix International Co Ltd
Macronix International Co Ltd have decreased by 0%.
Payout Ratio
Macronix International Co Ltd
| Current Payout | |
| Min Payout | |
| Max Payout | |
| Average Payout | |
| Median Payout |
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for
Macronix International Co Ltd is
.
Peers Comparison
Shareholder Yield
Price Appreciation
Price
Macronix International Co Ltd
| Average Annual Return | 51.45% |
| Standard Deviation of Annual Returns | 102.99% |
| Max Drawdown | -57% |
| Market Capitalization | 242.5B TWD |
| Shares Outstanding | 1 981 310 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Macronix International Co Ltd's latest stock split occurred on Aug 24, 2018
The company executed a 1020-for-1000 stock split, meaning that for every 1000 shares held, investors received 1020 new shares.
Before the split, Macronix International Co Ltd traded at 33.25 per share. Afterward, the share price was about 24.2797.
The adjusted shares began trading on Aug 24, 2018. This was stock split number 17 in Macronix International Co Ltd's history, following the previous one in Aug 15, 2017.